BKYI

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

Wall Street analysts forecast BKYI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKYI is 2.00 USD with a low forecast of 2.00 USD and a high forecast of 2.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

BIO-Key International Inc revenue for the last quarter amounts to 1.55M USD, decreased -27.75 % YoY.

BIO-Key International Inc. EPS for the last quarter amounts to -0.15 USD, decreased -61.54 % YoY.

BIO-Key International Inc (BKYI) has 41 emplpoyees as of December 16 2025.

Today BKYI has the market capitalization of 7.18M USD.